On ECHEMI
Home > Drugs > Empagliflozin Registered Holders
Empagliflozin structure

Empagliflozin structure

Empagliflozin

Empagliflozin is a selective sodium glucose cotransporter-2 (SGLT-2) inhibitor with an IC50 of 3.1 nM for human SGLT-2.

Find 81 Related Holders

AARTI PHARMALABS LTD
United States United States

API Registration Country

API Active
MATRIX PHARMACORP PRIVATE LTD
United States United States

API Registration Country

API Active
ALEMBIC PHARMACEUTICALS LTD
United States United States

API Registration Country

API Active
APITORIA PHARMA PRIVATE LTD
United States United States

API Registration Country

API Active
PIRAMAL PHARMA LTD
United States United States

API Registration Country

API Active
Granules India Ltd
United States United States

API Registration Country

API Active
ZYDUS LIFESCIENCES LTD
United States United States

API Registration Country

API Active
HIKAL LTD
United States United States

API Registration Country

API Active
COHANCE LIFESCIENCES LTD
United States United States

API Registration Country

API Active
  • Founded in:

    2005-09-28 00:00:00
  • Country:

    United States United States
MACLEODS PHARMACEUTICALS LTD
India India

API Registration Country

API Active
  • Founded in:

    1989-06-05 00:00:00
  • Country:

    India India
  • Address:

    304, ATLANTA ARCADE, MAROL CHURCH ROAD, ANDHERI (EAST) NA MUMBAI MH 400059 IN
  • Registered Funds:

    648.7 million INR
Recommended Suppliers of Empagliflozin
View 138 Suppliers Request for Quotation
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.